Acute coronary disease Athero-Inflammation: Therapeutic approach

AUTOR(ES)

Altman, Raul

FONTE

BioMed Central

RESUMO

Antithrombotic therapy is the cornerstone of the treatment of acute coronary syndromes, but there is now evidence which indicates that by blocking inflammation, thrombosis and thus, acute coronary events, could be lowered. The concept of athero-inflammation emerges as the meeting point of different morbidities; dyslipemia, diabetes, hypertension, obesity, immunity, infection, hyperhomocyteinemia, smoking, etc. usual named as risk factors. Thus, beside specific drugs, earliest treatment, in the stage of inflammation, using anti-inflammatory drugs, should be considered since in patients with increased risk of acute coronary process are likely to have many point of origen throughout the coronary arteries. There are a body of evidences for supporting the potential of anti-inflammatory therapy to the prevention of inflammation and atherosclerosis. COX-2 inhibition may decrease endothelial inflammation reducing monocytes infiltration improving vascular cells function, plaque stability and probably resulting in a decrease of coronary atherothrombotic events.

Documentos Relacionados

• Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
• Therapeutic approach to acute hepatitis C
• Therapeutic approach to pediatric acute mastoiditis – an update
• Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome
• The "common soil" theory: coronary disease, diabetes and inflammation